Actinium Pharmaceuticals, Inc.

ATNM·AMEX·$1.16Share Price as of 11/2·$36MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/07/26 10-QQ1 ended 03/31/2605/08/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/14/25 10-QQ2 ended 06/30/2508/08/25

Disclosures

8-KCurrent report10/15/26 8-KCurrent report08/14/26 8-KCurrent report06/18/26 8-KCurrent report05/29/26 8-K/ACurrent report (amended)03/26/26

Prospectuses and Registrations

S-8Registration of securities for employees10/09/26 S-8Registration of securities for employees03/29/24 S-3/AShelf registration (amended)02/02/24 S-3Shelf registration08/11/23 S-8Registration of securities for employees08/19/22

Proxies

DEF 14ADefinitive proxy10/16/26 DEF 14ADefinitive proxy11/05/25 DEF 14ADefinitive proxy11/05/24 DEF 14ADefinitive proxy11/09/23 DEFA14AAdditional proxy materials12/09/22

Ownership

Form 3Initial insider ownership10/16/26 Form 4Insider transaction10/16/26 Form 3Initial insider ownership09/10/26 Form 3Initial insider ownership09/10/26 Form 4Insider transaction09/04/26

Other

ARSAnnual report to shareholders10/15/26 ARSAnnual report to shareholders11/05/25 ARSAnnual report to shareholders11/06/24 EFFECTRequest for effectiveness02/05/24 CORRESPCorrespondence with the SEC02/02/24